Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
RADNOR, Pa.–(BUSINESS WIRE)–$MRNS #MarinusPharma—Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development... Read more.
Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe... Read more.
NextDecade Announces $50 Million Senior Secured Revolving Credit Facility and $12.5 Million Interest Term Loan
Provides Liquidity for General Corporate Purposes and Train 4 Development Costs HOUSTON–(BUSINESS WIRE)–NextDecade Corporation (NextDecade) (NASDAQ:... Read more.
Cencora Announces Date and Time for First Quarter Fiscal 2024 Earnings Release
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2024... Read more.
LuxUrban Hotels Declares Dividend on 13.00% Series A Cumulative Redeemable Preferred Stock
MIAMI–(BUSINESS WIRE)–LuxUrban Hotels Inc. (or the “Company”) (Nasdaq: LUXH, LUXHP), which utilizes an asset-light business model to lease entire... Read more.
Best’s Commentary: AM Best Expects Insured Losses from Japan Earthquake to Have Limited Credit Ratings Impact
HONG KONG–(BUSINESS WIRE)–#insurance—AM Best expects the earnings impact on the major domestic non-life insurers of losses stemming from the 1... Read more.
W. R. Berkley Corporation to Announce Fourth Quarter and Full Year 2023 Earnings on January 24, 2024
GREENWICH, Conn.–(BUSINESS WIRE)–W. R. Berkley Corporation (NYSE: WRB) will release its fourth quarter and full year 2023 earnings after the market closes... Read more.
UMB Announces Conference Call to Discuss Fourth Quarter and Full-Year 2023 Results
KANSAS CITY, Mo.–(BUSINESS WIRE)–UMB Financial Corporation (Nasdaq: UMBF), a financial services company, will release earnings results for the fourth... Read more.
Universal Display Corporation Announces Participation at Upcoming Conference
EWING, N.J.–(BUSINESS WIRE)–$OLED #OLED—Universal Display Corporation (Nasdaq: OLED) (UDC), enabling energy-efficient displays and lighting with... Read more.
Debiopharm and Repare Therapeutics Partner to Explore the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition in Cancer
Collaborative clinical study will investigate a novel combination of Debio 0123, Debiopharm’s potent, brain penetrant inhibitor of WEE1, and lunresertib, Repare... Read more.